BUTITTA CYNTHIA M bought URGN
June 22, 2026 · Form 4 insider transaction
BUTITTA CYNTHIA M bought 10,000 shares of UroGen Pharma Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$0.00
Total value
N/A
InsiderBUTITTA CYNTHIA M
RoleDirector
CompanyUroGen Pharma Ltd. (URGN)
SecurityStock Option (right ot buy)
Transaction codeA: Grant or award
Transaction dateJune 22, 2026
Filing dateJune 24, 2026
Shares owned after10,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.